Pinnacle Productions, Sponsored Small Cap News

LexaGene Working To Advance LX6 Pathogen Detection Instrument

June 14, 2018

[responsivevoice_button]

In our latest exclusive interview, Alexander Smith travels to Boston, Massachusetts to visit our client LexaGene (LXG: TSXV) at its newly leased 17,500-square-foot facility. LexaGene’s President and CEO, Dr. Jack Regan, shows us how the LX6 prototype functions by taking us through its typical pathogen detection process.

To learn more about LexaGene’s technology click here.

If you’re not already a member of our newsletter and you invest in TSX Venture stocks, what are you waiting for? Subscribe today. Only our best content will land in your inbox.

We want to hear from you

If you would like to write a message to Evan and his family, please fill in the form below:

Tired of reading?

Watch our exclusive videos, podcasts and more…

Exclusive Content

Latest Insights

Stories and trends that move markets.

Adrian Day’s Long Game on Gold and Commodities

Pinnacle Digest

Why Adrian Day remains bullish on gold following the Trump bump in equities…

Craftsmanship and Commodities from Italy to Canada, and the U.S.

Pinnacle Digest

Canada’s economy is largely underutilized, relying too heavily on natural resources…

Falling Birthrates, Economic Strain & Precious Metals…

Pinnacle Digest

Find out why falling birthrates, rising inflation, and soaring gold prices are connected…

Ultimate Guide to Investing in Junior Gold Stocks

For well over a century, gold stocks have been one of the most popular investment assets
among speculators. An essential fact sometimes ignored is that gold equities often drastically…

This site is proudly a part of Maximus Strategic Consulting Inc.

About Us

Education

Legal

Authors for PinnacleDigest.com are not registered broker-dealers or financial advisors. Before investing in any securities, you should consult with your financial advisor and a registered broker-dealer. Never make an investment based solely on what you read on PinnacleDigest.com. As with all investments, an investor should carefully consider his investment objectives and risk tolerance before investing. Use of this Site constitutes acceptance of our Terms of Use, Privacy Policy and Disclosure & Compensation. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Pinnacle Digest.

Securities covered in articles on this website are highly speculative. When investing in speculative stocks of this nature, it is possible to lose your entire investment over time or even quickly. These are not suitable investments for most investors.

All statements in articles on this website are to be checked and verified by the reader. Articles on this website may contain technical or other inaccuracies, omissions, or typographical errors for which PinnacleDigest.com assumes no responsibility.

Please be aware and note the date in which articles are published on this website. As a result of the passing of time, the relevancy of the opinions and facts in articles are likely to diminish over time and may change without an update to the articles. As such, you cannot rely on the accuracy and timeliness of the information provided and should consider many of the articles irrelevant after an extended period of time from the date which it was published. Since there is no specific guideline as to how long an article may remain relevant, you should consider that all articles may be irrelevant shortly after they are published. This is especially true for articles that include information on publicly traded companies.

LexaGene Working To Advance LX6 Pathogen Detection Instrument

We want to hear from you

Tired of reading?

Watch our exclusive videos, podcasts and more…

Latest Insights

Ultimate Guide to Investing in Junior Gold Stocks

About Us

Categories

Education

Legal

Market And Economic Insights From The World Of Venture Capital

Join The Community